Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
Abstract Crystallization is the bottleneck in macromolecular crystallography; even when a protein crystallises, crystal packing often influences ligand-binding and protein–protein interaction interfaces, which are the key points of interest for functional and drug discovery studies. The human hypoxi...
Saved in:
Main Authors: | Rasheduzzaman Chowdhury, Martine I. Abboud, Tom E. McAllister, Biswadip Banerji, Bhaskar Bhushan, John L. Sorensen, Akane Kawamura, Christopher J. Schofield |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/7ffb0667b88f4bb4a12b5e6a229217a5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
by: Rasheduzzaman Chowdhury, et al.
Published: (2016) -
Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.
by: Francesca Spinella, et al.
Published: (2010) -
Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair
by: Zhu K, et al.
Published: (2014) -
Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
by: Giada Zurlo, et al.
Published: (2019) -
Suppression of collagen IV alpha‐2 subunit by prolyl hydroxylase domain inhibition via hypoxia‐inducible factor‐1 in chronic kidney disease
by: Mohammad Sanaei‐Ardekani, et al.
Published: (2021)